Literature DB >> 11917526

CFTR folding and maturation in cells.

Mohamed Benharouga1, Manu Sharma, Gergely L Lukacs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11917526     DOI: 10.1385/1-59259-187-6:229

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


× No keyword cloud information.
  6 in total

1.  Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.

Authors:  Silvia M Kreda; Marcus Mall; April Mengos; Lori Rochelle; James Yankaskas; John R Riordan; Richard C Boucher
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

2.  The CFTR-Associated Ligand Arrests the Trafficking of the Mutant ΔF508 CFTR Channel in the ER Contributing to Cystic Fibrosis.

Authors:  Emily Bergbower; Clement Boinot; Inna Sabirzhanova; William Guggino; Liudmila Cebotaru
Journal:  Cell Physiol Biochem       Date:  2018-01-29

Review 3.  Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease.

Authors:  Margarida D Amaral
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

4.  The cystic fibrosis transmembrane conductance regulator impedes proteolytic stimulation of the epithelial Na+ channel.

Authors:  Martina Gentzsch; Hong Dang; Yan Dang; Agustin Garcia-Caballero; Hamsa Suchindran; Richard C Boucher; M Jackson Stutts
Journal:  J Biol Chem       Date:  2010-08-13       Impact factor: 5.157

5.  Clinical and molecular characterization of S1118F-CFTR.

Authors:  Himabindu Penmatsa; Carla A Frederick; Sunitha Nekkalapu; Veronica G Conoley; Weiqiang Zhang; Chunying Li; John Kappes; Dennis C Stokes; Anjaparavanda P Naren
Journal:  Pediatr Pulmonol       Date:  2009-10

6.  Substitution of Yor1p NBD1 residues improves the thermal stability of Human Cystic Fibrosis Transmembrane Conductance Regulator.

Authors:  B M Xavier; E Hildebrandt; F Jiang; H Ding; J C Kappes; I L Urbatsch
Journal:  Protein Eng Des Sel       Date:  2017-10-01       Impact factor: 1.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.